COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT00334932
Brief Title: Doxorubicin Hydrochloride Liposome, Melphalan, and Bortezomib in Treating Patients With Relapsed or Refractory Stage I, Stage II, or Stage III Multiple Myeloma

First Submitted : June 7, 2006
First Submitted that Met QC Criteria : June 7, 2006
First Posted : June 8, 2006 (Estimate)

Last Update Submitted that Met QC Criteria : January 9, 2014
Last Update Posted : January 10, 2014 (Estimate)